TKI- 購入

  • 商品説明・詳細

  • 送料・お届け

商品情報

未使用


着払いで発送します

TKI - Tiroler Kulturinitiativen
TKI - Tiroler Kulturinitiativen

Managing common toxicities with new tyrosine kinase inhibitors | Cancer  World Archive
Managing common toxicities with new tyrosine kinase inhibitors | Cancer World Archive

Treatment-free remission after a second TKI discontinuation attempt in  patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim  results from the DAstop2 trial | Leukemia
Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial | Leukemia

Erlotinib is an EGFR TKI for NSCLC and Pancreatic Cancer Research - Network  of Cancer Research
Erlotinib is an EGFR TKI for NSCLC and Pancreatic Cancer Research - Network of Cancer Research

Tyrosine Kinase-Inhibitor (TKI)-sensitive and-resistant Tumors and the... |  Download Scientific Diagram
Tyrosine Kinase-Inhibitor (TKI)-sensitive and-resistant Tumors and the... | Download Scientific Diagram

Molecular and Clinical Features of EGFR-TKI-Associated Lung Injury
Molecular and Clinical Features of EGFR-TKI-Associated Lung Injury

TKI Group
TKI Group

MET Amplification as a Resistance Driver to TKI Therapies in Lung Cancer:  Clinical Challenges and Opportunities
MET Amplification as a Resistance Driver to TKI Therapies in Lung Cancer: Clinical Challenges and Opportunities

Lymecycline reverses acquired EGFR-TKI resistance in non–small-cell lung  cancer by targeting GRB2 - ScienceDirect
Lymecycline reverses acquired EGFR-TKI resistance in non–small-cell lung cancer by targeting GRB2 - ScienceDirect

Tki Images – Browse 167 Stock Photos, Vectors, and Video | Adobe Stock
Tki Images – Browse 167 Stock Photos, Vectors, and Video | Adobe Stock

An Overview of the TKI Assessment Tool - Kilmann Diagnostics
An Overview of the TKI Assessment Tool - Kilmann Diagnostics

Mechanisms and management of 3rd‑generation EGFR‑TKI resistance in advanced  non‑small cell lung cancer (Review)
Mechanisms and management of 3rd‑generation EGFR‑TKI resistance in advanced non‑small cell lung cancer (Review)

Das TKI Werkzeug – Umgang und Lösen von Konflikten am Arbeitsplatz
Das TKI Werkzeug – Umgang und Lösen von Konflikten am Arbeitsplatz

Olafertinib is a Third-Generation EGFR TKI - Network of Cancer Research
Olafertinib is a Third-Generation EGFR TKI - Network of Cancer Research

The mechanisms of acquired EGFR-TKI resistance. (a) The illustration of...  | Download Scientific Diagram
The mechanisms of acquired EGFR-TKI resistance. (a) The illustration of... | Download Scientific Diagram

残り 2 59,800円

(988 ポイント還元!)

翌日お届け可(営業日のみ) ※一部地域を除く

お届け日: 12月25日〜指定可 (明日16:00のご注文まで)

  • ラッピング
    ラッピング
希望しない
希望する ( +600円 )
希望しない
数量
同時に5点までのご購入が可能です。
お気に入りに保存

対応決済方法

クレジットカード
クレジットカード決済
コンビニ前払い決済
コンビニ決済
代金引換
商品到着と引き換えにお支払いいただけます。 (送料を含む合計金額が¥292,004 まで対応可能)
ペイジー前払い決済(ATM/ネットバンキング)
以下の金融機関のATM/ネットバンクからお支払い頂けます
みずほ銀行 、 三菱UFJ銀行 、 三井住友銀行
りそな銀行 、ゆうちょ銀行、各地方銀行
Amazon Pay(Amazonアカウントでお支払い)

大量注文に関して

30個以上かつ10万円以上のご購入はこちらからお問い合わせください

お問い合わせはこちらから